logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

GlaxoSmithKline Share Price

GlaxoSmithKline Pharmaceuticals Ltd.

₹2,357

2.70(0.11%)

Invest in GLAXO with up to 2.50x margin.

Trade with MTF
9th Apr 2026 | 3:28 PM
NSE : GLAXO
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

GlaxoSmithKline Performance

Price Movement

₹2357.00

₹2345.00

₹2374.30

↘ Today's Low↗ Today's High

1 Year Performance

₹2357.00

₹2217.60

₹3515.70

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,374.30
Low₹2,345.00
Open at₹2,354.30
Prev Close₹2,354.30
Volumes23.61 K
Avg Price₹2,361.96
Lower Circuit₹1,883.50
Upper Circuit₹2,825.10

Historical Performance

3M High₹2,719.80
3M Low₹2,217.60
1 Yr High₹3,515.70
1 Yr Low₹2,217.60
3 Yr High₹3,515.70
3 Yr Low₹1,227.00
5 Yr High₹3,515.70
5 Yr Low₹1,227.00

GlaxoSmithKline Fundamentals

Market Cap
High in industry
39,974.70 Cr.
PE Ratio (TTM)
Above industry Median
39.20
Dividend Yield
High in industry
1.80
Net Profit TTM
18.8% incr over last year
1,020.99
Net Profit Growth
18.8% incr over last year
1,020.99
PEG Ratio
High in industry
2.10
ROE
42.6% incr over last year
47.67
Operating Revenue TTM
3,800.74
Operating Revenue Growth
2.6% incr over last year
Book Value
High in industry
20
MFI
MFI is mid-range
49.45
RSI
RSI is mid-range
44.91
EPS (TTM)
54.52
Debt to Equity
0
Face Value
10
Operating Profit Margin Qtr.
30.23
Operating Profit Qtr.
371.34
Net Profit Qtr.
295.62
Operating Revenue Qtr.
1,041.26
PB Ratio
20

GlaxoSmithKline Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue1,022.59973.63804.83966.08946.36
Operating Expense655.01638.95554.08635.34656.18
Operating Profit367.58334.68250.75330.74290.18
Depreciation20.3217.4315.5214.7218.80
Interest1.190.510.420.580.09
Tax100.7195.6573.8794.7677.77
Net Profit277.18255204.70260.14228.58

GlaxoSmithKline Technicals

GlaxoSmithKline Pharmaceuticals Ltd. EMA & SMA

₹2357.00

2.70 (0.11%)

↗ Bullish Moving Average

5

↘ Bearish Moving Average

11

Day EMA5 ₹2335.8
Day EMA10 ₹2340.1
Day EMA12 ₹2346.6
Day EMA20 ₹2376
Day EMA26 ₹2394.1
Day EMA50 ₹2436.5
Day EMA100 ₹2499.2
Day EMA200 ₹2576.4

GlaxoSmithKline Support and Resistance

Resistance

First Resistance₹2384.80
Second Resistance₹2415.30
Third Resistance₹2433.70

Support

First Support₹2335.90
Second Support₹2317.50
Third Support₹2287.00

Technical Indicators

Day RSI44.91
Day MFI49.45
Day ADX23.84
Day Commodity Channel Index-15.70
William-46.27
Day MACD-47.53
Day MACD Signal Line-50.01
Day ATR71.63
Day ROC125-14.26
Day ROC21-5.04

GlaxoSmithKline Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter757575757575
FII4.44.54.54.954.6
DII7.37.37.87.787.7
Public13.313.212.712.41212.7

GlaxoSmithKline Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day36.11 K57.97 K62.30%
Week40.57 K66.86 K60.68%
1 Month34.83 K60.72 K57.36%
6 Month48.36 K79.81 K60.60%

GlaxoSmithKline SWOT Analysis

Strengths22
Weakness6
Opportunity1
Threats2

MACD Crossover Above Signal Line

Companies with no Debt

Benjamin Graham Value Screen

Stocks in Buy Zone with High Momentum Score Last Month

Mid-range Performer (DVM)

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

MACD crossed above signal line previous end of day

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

GlaxoSmithKline Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
30 May, 202542FINAL30 May, 2025Equity Share
07 Nov, 202412INTERIM07 Nov, 2024Equity Share
31 May, 202432FINAL31 May, 2024Equity Share
30 Jun, 202332FINAL30 Jun, 2023Equity Share
07 Jul, 202260SPECIAL08 Jul, 2022Equity Share
07 Jul, 202230FINAL08 Jul, 2022Equity Share
19 Jul, 202130FINAL20 Jul, 2021Equity Share
17 Jul, 202020SPECIAL20 Jul, 2020Equity Share
17 Jul, 202020FINAL20 Jul, 2020Equity Share
11 Jul, 201920FINALEquity Share

GlaxoSmithKline Stock Comparison

Financials
Anthem Biosciences Ltd.
Sai Life Science Ltd.
Emcure Pharmaceuticals Ltd.
Mankind Pharma Ltd.
Gland Pharma Ltd.
Laurus Labs Ltd.
Price (₹)₹720₹975₹1,604₹2,053₹1,745.10₹1,081.95
% Change4.24%0.15%2.47%0.54%0.96%-0.05%
Revenue TTM (₹ Cr)₹1,996.59₹2,169.86₹8,850.08₹13,914.08₹6,112.77₹6,721.63
Net Profit TTM (₹ Cr)₹484.66₹332.94₹869.92₹1,779.35₹847.18₹843.32
PE TTM83.5062.2035.0047.7034.0069.40
1 Year Return26.3643.5670.22-12.4922.787.09
ROCE26.8812.5120.8013.2711.4311.82

FAQ's on GLAXO

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy